Federated Hermes’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.9M Sell
183,137
-121,974
-40% -$6.59M 0.02% 606
2026
Q1
$15.9M Buy
305,111
+304,446
+45,781% +$18.3M 0.03% 520
2025
Q4
$39.1K Sell
665
-5
-0.7% -$304 ﹤0.01% 1668
2025
Q3
$37.3K Buy
+670
New +$35.9K ﹤0.01% 1715
2025
Q2
Sell
-695
Closed -$40.7K 2183
2025
Q1
$40.7K Buy
+695
New +$47.1K ﹤0.01% 1654
2023
Q4
Sell
-691
Closed -$47K 2203
2023
Q3
$47K Buy
+691
New +$54.6K ﹤0.01% 1674
2023
Q1
Sell
-1,084
Closed -$89.8K 2256
2022
Q4
$89.8K Sell
1,084
-316
-23% -$25.1K ﹤0.01% 1640
2022
Q3
$99K Hold
1,400
﹤0.01% 1611
2022
Q2
$121K Buy
+1,400
New +$131K ﹤0.01% 1599
2022
Q1
Sell
-1,528
Closed -$198K 2311
2021
Q4
$198K Buy
1,528
+360
+31% +$44.1K ﹤0.01% 1640
2021
Q3
$141K Sell
1,168
-27,860
-96% -$3.39M ﹤0.01% 1724
2021
Q2
$3.27M Sell
29,028
-41,492
-59% -$4.37M 0.01% 952
2021
Q1
$6.73M Buy
70,520
+39,116
+125% +$3.57M 0.01% 767
2020
Q4
$2.49M Sell
31,404
-2,020
-6% -$146K 0.01% 987
2020
Q3
$2.07M Sell
33,424
-3,396
-9% -$221K ﹤0.01% 974
2020
Q2
$2.43M Sell
36,820
-3,760
-9% -$225K 0.01% 929
2020
Q1
$1.92M Sell
40,580
-2,244
-5% -$112K 0.01% 907
2019
Q4
$2.35M Sell
42,824
-3,716
-8% -$195K 0.01% 979
2019
Q3
$2.28M Sell
46,540
-7,756
-14% -$389K 0.01% 998
2019
Q2
$2.83M Buy
54,296
+4,228
+8% +$213K 0.01% 952
2019
Q1
$2.48M Sell
50,068
-2,320
-4% -$104K 0.01% 977
2018
Q4
$1.9M Sell
52,388
-12,456
-19% -$520K 0.01% 1054
2018
Q3
$3.31M Sell
64,844
-3,348
-5% -$148K 0.01% 925
2018
Q2
$2.52M Buy
68,192
+6,352
+10% +$243K 0.01% 919
2018
Q1
$2.33M Buy
61,840
+2,040
+3% +$72.1K 0.01% 901
2017
Q4
$1.94M Sell
59,800
-9,108
-13% -$289K 0.01% 948
2017
Q3
$2.08M Buy
68,908
+10,668
+18% +$317K 0.01% 891
2017
Q2
$1.71M Sell
58,240
-21,268
-27% -$581K ﹤0.01% 993
2017
Q1
$2.02M Sell
79,508
-2,516
-3% -$64.9K 0.01% 912
2016
Q4
$2.11M Sell
82,024
-2,500
-3% -$65.7K 0.01% 845
2016
Q3
$2.31M Sell
84,524
-2,276
-3% -$62.5K 0.01% 797
2016
Q2
$2.45M Buy
86,800
+2,300
+3% +$59.1K 0.01% 765
2016
Q1
$2M Sell
84,500
-2,544
-3% -$56K 0.01% 842
2015
Q4
$1.96M Sell
87,044
-224,912
-72% -$5.13M 0.01% 878
2015
Q3
$7.21M Buy
311,956
+1,392
+0.4% +$34.9K 0.02% 490
2015
Q2
$7.64M Sell
310,564
-11,052
-3% -$276K 0.02% 511
2015
Q1
$8.06M Buy
321,616
+64,584
+25% +$1.54M 0.02% 502
2014
Q4
$5.94M Buy
257,032
+166,648
+184% +$3.81M 0.02% 561
2014
Q3
$2.11M Buy
90,384
+10,204
+13% +$239K 0.01% 951
2014
Q2
$1.86M Sell
80,180
-8,008
-9% -$177K 0.01% 986
2014
Q1
$1.88M Sell
88,188
-19,056
-18% -$429K 0.01% 974
2013
Q4
$2.54M Sell
107,244
-4,176
-4% -$90.5K 0.01% 837
2013
Q3
$2.23M Sell
111,420
-5,856
-5% -$111K 0.01% 860
2013
Q2
$2.02M Buy
+117,276
New +$1.95M 0.01% 877

Other funds holding TECH

Federated Hermes's TECH Position: Q2 2026 in Review

Federated Hermes reduced its Bio-Techne (TECH) stake by 40% in Q2 2026, selling an estimated $6.59M and leaving 183,137 shares worth $12.9M. The position accounts for 0.02% of the portfolio, ranked #606.

Federated Hermes first reported a position in TECH in Q2 2013 and has held it in 44 quarters since. The position peaked at $15.9M in Q1 2026. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Federated Hermes held 183,137 shares of Bio-Techne worth $12.9M as of Q2 2026.
  • Federated Hermes sold 121,974 Bio-Techne shares in Q2 2026, an estimated $6.59M.
  • Bio-Techne made up 0.02% of Federated Hermes's portfolio in Q2 2026, its #606 holding.
  • Federated Hermes first reported a position in Bio-Techne in Q2 2013 and has held it in 44 quarters since.
  • Federated Hermes's Bio-Techne position peaked at $15.9M in Q1 2026.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.